Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
24,393,021
-
Shares change
-
+561,183
-
Total reported value, excl. options
-
$1,025,484,934
-
Value change
-
+$23,061,213
-
Number of buys
-
45
-
Number of sells
-
46
-
Price
-
$42.04
Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q4 2018
As of 31 Dec 2018 Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) had 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,393,021 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, BOXER CAPITAL, LLC, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., BB BIOTECH AG, FMR LLC, Point72 Asset Management, L.P., and ArrowMark Colorado Holdings LLC.
This table shows 91 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.